Identification of receptor-binding sites of monocyte chemotactic S19 ribosomal protein dimer

American Journal of Pathology

Volumn 159, Issue 6, 2001, Pages 2293-2301

  Shibuya, Yoko ^a   Shiokawa, Megumi ^a,b   Nishiura, Hiroshi ^b   Nishimura, Takumasa ^b   Nishino, Norikazu ^c   Okabe, Hiroaki ^a   Takagi, Katsumasa ^a   Yamamoto, Tetsuro ^b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c KYUSHU INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A RECEPTOR; DIMER; MONOCYTE CHEMOTACTIC PROTEIN; RECOMBINANT PROTEIN; RIBOSOME PROTEIN; SYNTHETIC PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CHEMOTAXIS; DNA FLANKING REGION; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR UPREGULATION; SEQUENCE HOMOLOGY; SITE DIRECTED MUTAGENESIS;

EID: 0035180454     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63079-9     Document Type: Article

References (24)

1. Monocyte chemotactic factor in rheumatoid arthritis synovial tissue: Probably a cross-linked derivative of S19 ribosomal protein
2. Yamamoto T: Determination of the cross-linked residues in homo-dimerization of S19 ribosomal protein concomitant with exhibition of monocyte chemotactic activity
3. Apoptotic cells of an epithelial cell line, AsPC-1, release monocyte chemotactic S19 ribosomal protein dimer
4. A monocyte chemotactic factor, S19 ribosomal protein dimer, in phagocytic clearance of apoptotic cells
5. S19 ribosomal protein cross-linked dimer causes monocyte-predominant infiltration by means of molecular mimicry to complement C5a
6. The chemotactic receptor for human C5a anaphylatoxin
7. Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells
8. Structural definition of the C5a C terminus by two-dimensional nuclear magnetic resonance spectroscopy
9. Identification of receptor-binding residues in the inflammatory complement protein CSa by site-directed mutagenesis
10. The pharmacophore of the human C5a anaphylatoxin
11. Probing the Message: Address sites for chemoattractant binding to the C5a receptor. Mutagenesis of hydrophilic and proline residues within the transmembrane segments
12. Springer MS: Arginine 206 of the C5a receptor is critical for ligand recognition and receptor activation by C-terminal hexapeptide analogs
13. Biological activity of synthetic analogues of C5a anaphylatoxin
14. Biologically active conformer of the effector region of human C5a and modulator effects of N-terminal receptor binding determinants on activity
15. Solution structure of a unique C5a semi-synthetic antagonist: Implications in receptor binding
16. Two-site binding of C5a by its receptor: An alternative binding paradigm for G protein-coupled receptors
17. Development of C5a receptor antagonists: Differential loss of functional responses
18. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin: Polypeptide sequence determination and assignment of the oligosac-charide attachment site in C5a
19. Complement C4 derived monocyte-directed chemotaxis-inhibitory factor
20. Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class 1 messenger RNAs associated with colon carcinoma progression and differentiation
21. Mutagenesis by the polymerase chain reaction
22. A system for rapid DNA sequencing with fluorescent chain-terminating dideoxynucleotides
23. A 48 well micro-chemotaxis assembly for rapid and accurate measurement of leukocyte migration
24. 2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding